10 / 16
Page 25
allied
academies
Current Trends in Cardiology | Volume: 03
10
th
WORLD HEART CONGRESS
&
6
th
International Congress on
CARDIOLOGY AND CARDIAC SURGERY
December 02-03, Dubai, UAE
Joint event on
Curr Trend Cardiol, Volume: 03
ECP–Asimple, non-invasivesolution to thecomplexproblemof CADandHeart Failure
(New hope for CAD & HF Patients)
Anupam Shrivastav
Heart Care, India
M
odern life-style is responsible to increasing number
of CAD patients worldwide. Coronary Heart Disease
has come out as the biggest killer of human population in
past 2-3 decades. CAD / CHD, is basically a systemic disease
in which a part or parts of myocardium do not get proper
blood supply through coronaries, due to blockages or
narrowing of the vessels. Surprisingly, in spite of the large
number of morbidity & mortality caused by this disease,
the measures to check or reverse the disease process are
either not sufficient or not in the proper direction.
Initially CABG, then due to high morbidity and mortality
followed by so many post surgical complications, focus
was shifted towards balloon Angioplasty, BM Stents, DES/
Medicated Stents, but due to higher rates of restenosis &
other complications, now DEB (Drug Eluting Balloon) & bio
absorbable stents are highlighted.
But, we must hold all this & think are we going towards
right direction?
Now in 21st Century External Counter Pulsation (ECP)
has come into light as the first Non-invasive, Non-
pharmacological USFDA approved treatment modality,
which is performed without hospitalization as an outdoor
procedure, without any anesthesia, without any risk,
without any peri or post procedure complications and
without pain. Patients treated with ECP therapy, in various
trials and in thousands of ECP centers all over the world, all
the ‘ECP Experts’ have demonstratedmarked improvement
in all aspects in terms of functional angina class, increased
exercise tolerance, and a reduction in nitroglycerin use
also in all kind of myocardial perfusion assessment like MPI
scan by SPECT, Stress ECG and PET scan. These benefits
have been demonstrated in terms of increased myocardial
perfusion & enhancement in LVEF, remain durable in many
patients from 5 to even 12 years after treatment. ECP has
come out as a proven non-invasive treatment modality for
Stable CAD & Heart Failure patients. It fulfills all the criteria
for a successful CAD / LV dysfunction treatment as defined
by ACC/AHA in their published Guidelines. By this unique
treatment, presently we are treating patients of CAD/ LVF/
CHF those who are either Unfit or Unwilling for Invasive or
surgical revascularization.
ECP is a very good choice, also when it remains a big
confusion in the mind of treating consultant, whether, to
send any particular patient for PCI or not. Similarly patient
who developed re-stenosis or re-blockages after Stent
implantation, then ECP remains very good option to save
that patient from the risk and complications of CABG. In
post CABG cases, ECP is the safest option and provides
very good all round symptomatic relief & hemodynamic
improvement. ECP remains the only treatment option
for those CAD patients who are having diffuse or micro-
vascular disease including Diabetics & women.
ECP treatment provides numerous all round benefits
including even Non-cardiac improvements to all the
cardiac patients.
Now, it is the right time to change our mind-set for the
benefits of CAD patient community and provide them the
best & safest treatment available in present days, i.e. ECP,
which provide lot of all round benefits and no harm.
e:
anupam.cardio@gmail.com